From Chromadex press release and link to the full independent study that was published yesterday:
"...supplementation with the unique B3 vitamin nicotinamide riboside (NR, or Niagen®) helps maintain heart function in mice by stimulating a conserved cellular response called the “mitochondrial unfolded protein response” (UPRmt) that helps maintain mitochondrial function.
The study also presents preliminary human data to support future testing of NR in humans. Conducted by Principal Investigators Prof. Ajay M. Shah and Dr. Ioannis Smyrnias, Kings College London, the independent study results were published yesterday in the Journal of the American College of Cardiology (JACC). This study follows clinical results from last year highlighting the potential for NR supplementation to improve cardiovascular health.
“NR supplementation is a new and exciting intervention that merits testing in the human treatment of heart failure and other cardiac conditions,” said Prof. Shah. “These study findings showing the potential of NR to activate UPRmt are extremely encouraging and merit further research into the potential for NR to impact human cardiac health.”
In several complementary experiments, the authors found that increasing NAD levels with NR stimulated the UPRmt in cells and mice. Additionally, NR helped improve mitochondrial function and maintained the heart’s ability to pump blood.
To begin to investigate whether these findings might translate to humans, the study authors collected heart tissue samples from people and found positive correlations between increased UPRmt activation and markers of healthy heart function. Human studies were performed under institutional ethical approval and with informed consent.
Published in the Journal of the American College of Cardiology
Volume 73, Issue 14, April 2019
DOI: 10.1016/j.jacc.2018.12.087
"...this is the first study to identify activation of the UPRmt in response to diverse in vitro and in vivo stresses in the mammalian myocardium. We also show that pharmacological boosting of the UPRmt preserves mitochondrial function and cardiomyocyte viability under pathological stress conditions relevant to heart failure. Taken together, the results suggest that the targeting of the UPRmt merits further investigation as a therapeutic strategy for heart failure.
http://www.onlinejac...tent/73/14/1795
Edited by Fredrik, 09 April 2019 - 04:13 PM.